Partners & Licensees

In addition to our own clinical programs, REGENXBIO has enabled the development of gene therapies based on the NAV® Technology platform across a broad range of therapeutic areas and disease indications by our NAV® Technology Licensees.

Partnerships and licensing are a key part of REGENXBIO’s commitment to enabling the ongoing development of gene therapy treatments using our NAV® Technology Platform.

Contact us to discuss partnering or licensing opportunities.